HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Protective effects of early CD4(+) T cell reduction in hepatic ischemia/reperfusion injury.

AbstractAIM:
CD4(+) T cells contribute to disturbances of liver microcirculation after warm ischemia/reperfusion (I/R). The aim of this study was to investigate a possible protective role of FTY720 (Sphingosine-1 phosphate receptor agonist) in this setting.
MATERIAL AND METHODS:
In an in vivo model (42 Wistar rats), ischemia of the left liver lobe was induced for 90 min under anesthesia with xylazine/ketanest. Sham-operated untreated ischemic and treatment group with FTY720 (1 mg/kg body weight intravenous) were investigated. The effect of FTY on I/R injury was assessed by in vivo microscopy 30-90 min after reperfusion (perfusion rate, vessel diameter, leukocyte-endothelial cell interactions, T cell infiltration), by measurement of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), reverse transcription-polymerase chain reaction (RT-PCR) of interleukin (IL)-2, IL-6, IL-10, TNF-alpha, toll-like receptor 4 (TLR-4), and by histological investigation.
RESULTS:
After 30 min of reperfusion, the number of T cells in sinusoids was increased four-fold. In the FTY group, the number of T cells was reduced to an half of the number of the ischemia group. Likewise, the number of adherent leukocytes in sinusoids (150.8 +/- 10.9% of s.o.) was reduced in the treatment group (117.3 +/- 12.2%; p < 0.05 vs ischemia), leading to an improvement in perfusion rate in this group (85.0 +/- 4.6% of sham group) compared to nontreated animals (57.5 +/- 10.8%; p < 0.05). According to improved microcirculation, AST/ALT values and histological tissue damage were reduced in the therapy group. RT-PCR revealed an increased expression of IL-2, IL-6, and TLR-4 in the nontreated ischemic group. This expression was clearly reduced in the treatment group.
CONCLUSION:
In conclusion, FTY720 ameliorates the microcirculatory, biochemical, and histological manifestations of hepatic I/R injury by preventing T cell infiltration. These results indicate that T cells are pivotal mediators in hepatic I/R and may have important implications early after liver transplantation and in warm ischemia.
AuthorsMathias Martin, Christina Mory, Andrea Prescher, Christian Wittekind, Martin Fiedler, Dirk Uhlmann
JournalJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (J Gastrointest Surg) Vol. 14 Issue 3 Pg. 511-9 (Mar 2010) ISSN: 1873-4626 [Electronic] United States
PMID19937475 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Cytokines
  • Receptors, Lysosphingolipid
  • Toll-Like Receptor 4
  • Aspartate Aminotransferases
  • Alanine Transaminase
Topics
  • Alanine Transaminase (analysis)
  • Animals
  • Aspartate Aminotransferases (analysis)
  • Biomarkers (blood)
  • CD4 Lymphocyte Count
  • Cytokines (analysis)
  • Disease Models, Animal
  • Female
  • Immunohistochemistry
  • Liver Circulation (drug effects, physiology)
  • Liver Diseases (immunology, pathology, prevention & control)
  • Microcirculation (drug effects, physiology)
  • Microscopy, Fluorescence
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Receptors, Lysosphingolipid (antagonists & inhibitors)
  • Reperfusion Injury (immunology, pathology, prevention & control)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sensitivity and Specificity
  • T-Lymphocyte Subsets (metabolism)
  • Toll-Like Receptor 4 (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: